ArticleOncotarget2017

Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases.

Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.